HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Piero Sestili Selected Research
Piero Sestili Research Topics
Disease
12
Neoplasms (Cancer)
06/2021 - 11/2009
7
COVID-19
08/2021 - 01/2020
5
Leukemia
12/2021 - 02/2013
4
Inflammation (Inflammations)
01/2021 - 10/2011
3
Virus Diseases (Viral Diseases)
08/2021 - 01/2020
2
Cardiotoxicity
01/2022 - 08/2012
2
Cytokine Release Syndrome
08/2021 - 07/2021
2
Thrombosis (Thrombus)
08/2021 - 07/2021
2
Fatigue
01/2020 - 12/2018
2
Sarcopenia
01/2018 - 01/2017
2
Hemolytic-Uremic Syndrome
02/2013 - 05/2007
1
Hypoxia (Hypoxemia)
08/2021
1
Dengue (Dengue Fever)
08/2021
1
Anaphylaxis (Anaphylactic Shock)
08/2021
1
Intracranial Sinus Thrombosis (Sinus Thrombosis)
08/2021
1
Thrombocytopenia (Thrombopenia)
08/2021
1
Kounis Syndrome
08/2021
1
Hypotension (Low Blood Pressure)
08/2021
1
Rheumatoid Arthritis
07/2021
1
Infections
07/2021
1
Primary Myelofibrosis (Myelosclerosis)
07/2021
1
Tendinopathy (Tendonitis)
03/2021
1
Edema (Dropsy)
01/2021
1
Superinfection
01/2020
1
Fever (Fevers)
01/2020
1
Human Influenza (Influenza)
01/2020
1
Pain (Aches)
01/2020
1
Interstitial Lung Diseases (Interstitial Lung Disease)
01/2020
1
Respiratory Tract Infections (Respiratory Tract Infection)
12/2019
1
Cognitive Dysfunction
08/2019
1
Breast Neoplasms (Breast Cancer)
01/2019
1
Genomic Instability
01/2019
1
Osteoporotic Fractures
01/2018
1
Osteoporosis
01/2018
1
Skin Diseases (Skin Disease)
01/2017
1
Muscular Atrophy (Muscle Atrophy)
01/2016
1
Atherosclerosis
09/2014
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2014
Drug/Important Bio-Agent (IBA)
4
sulforaphane
IBA
12/2021 - 07/2010
3
Pharmaceutical Preparations
IBA
07/2021 - 08/2012
3
Antioxidants
IBA
01/2017 - 01/2016
3
RNA (Ribonucleic Acid)
IBA
07/2013 - 11/2009
2
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2022 - 08/2012
2
Vaccines
IBA
08/2021 - 01/2020
2
Cytokines
IBA
08/2021 - 10/2011
2
Oxygen (Dioxygen)
IBA
07/2021 - 01/2019
2
Biological Products
IBA
01/2020 - 01/2020
2
Antiviral Agents (Antivirals)
IBA
01/2020 - 01/2020
2
Proteins (Proteins, Gene)
FDA Link
01/2020 - 01/2019
2
Phytochemicals
IBA
10/2019 - 01/2016
2
Creatine
IBA
08/2019 - 01/2017
2
isothiocyanic acid
IBA
01/2015 - 07/2010
2
DNA (Deoxyribonucleic Acid)
IBA
02/2013 - 11/2009
2
Shiga Toxin 1 (SLT-I)
IBA
02/2013 - 05/2007
1
Heparin (Liquaemin)
FDA Link
Generic
08/2021
1
baricitinib
IBA
07/2021
1
remdesivir
IBA
07/2021
1
ruxolitinib
IBA
07/2021
1
Janus Kinase Inhibitors
IBA
07/2021
1
Janus Kinases
IBA
07/2021
1
Mutagens
IBA
06/2021
1
Aflatoxins
IBA
06/2021
1
Hyaluronic Acid (Hyaluronan)
IBA
03/2021
1
Coffee
FDA Link
01/2021
1
Peptide Hydrolases (Proteases)
FDA Link
01/2021
1
Free Radicals
IBA
01/2021
1
Enzymes
IBA
01/2021
1
N-Acetylneuraminic Acid (Sialic Acid)
IBA
01/2021
1
piperine
IBA
11/2020
1
Branched-Chain Amino Acids
IBA
01/2020
1
Chromones
IBA
01/2020
1
Chloroquine (Aralen)
FDA Link
Generic
01/2020
1
Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
IBA
01/2020
1
Glutathione (Reduced Glutathione)
IBA
01/2020
1
surfactin A
IBA
01/2020
1
Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
IBA
01/2020
1
Angiotensin-Converting Enzyme 2
IBA
01/2020
1
Mast Cell Stabilizers
IBA
01/2020
1
Acetaminophen (Paracetamol)
FDA Link
Generic
01/2020
1
tocilizumab (atlizumab)
FDA Link
01/2020
1
Electrolytes
IBA
12/2019
1
Glycogen
IBA
12/2019
1
Proteasome Endopeptidase Complex (Proteasome)
IBA
10/2019
1
Tamoxifen
FDA Link
Generic
01/2019
1
Estrogen Receptors
IBA
01/2019
1
Explosive Agents (Explosives)
IBA
12/2018
1
coenzyme Q10 (CoQ10)
IBA
01/2017
1
Cytostatic Agents
IBA
12/2016
1
Hydrolyzable Tannins
IBA
01/2016
1
Gonadal Steroid Hormones (Sex Hormones)
IBA
09/2014
Therapy/Procedure
5
Therapeutics
11/2020 - 01/2015
2
Chemoprevention
01/2021 - 01/2016
2
Drug Therapy (Chemotherapy)
01/2017 - 12/2016
1
Oral Administration
07/2021
1
Artificial Respiration (Mechanical Ventilation)
07/2021
1
Extracorporeal Membrane Oxygenation
07/2021
1
Injections
03/2021
1
Patient Isolation
11/2020
1
Polypharmacy
01/2020
1
Long-Term Care
01/2018